CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2024; 8: (1) ; 83-86 ; DOI: 10.12208/j.ijcr.20240022.

Research progress on the role of cytokines in the pathogenesis of diabetes retinopathy
细胞因子在糖尿病视网膜病变发病中的作用研究进展

作者: 李承泽, 宿星杰 *

佳木斯大学附属第一医院 黑龙江佳木斯

*通讯作者: 宿星杰,单位:佳木斯大学附属第一医院 黑龙江佳木斯;

发布时间: 2024-01-20 总浏览量: 155

摘要

糖尿病,作为一种代谢性疾病,其主要症状为高血糖。糖尿病视网膜病变(DR),即糖尿病所引发的眼部慢性微血管炎症病变,其生成根源在于眼内血管长时间处于高血糖状态,导致氧化还原平衡失调、氧化应激以及慢性轻度炎症反应等问题,DR被视为糖尿病较为严重的并发症之一。目前,糖尿病(DM)在中国的患病比例持续增长,同时DR的发病比例也在持续攀升,已经成为中国最高的失明眼病。DR的形成过程极为复杂,是一种由多种因素引起的逐渐恶化的疾病,尽管目前对于DR具体形成原理尚不明确,但有相关研究指出,细胞因子和DR的形成和演变存在某种程度的相互影响。为深化细胞因子对DR影响的理解,本文将对炎症指数、血管增殖相关因子以及趋化因子等与DR之间的关联进行深入探讨,以期为糖尿病视网膜病变的研究提供理论依据。

关键词: 细胞因子;糖尿病;视网膜病变;研究进展

Abstract

Diabetes, as a metabolic disease, its main symptom is hyperglycemia. Diabetic retinopathy (DR) is the chronic ocular microvascular inflammation caused by diabetes. The root cause of DR is that the blood vessels in the eye are in a state of hyperglycemia for a long time, leading to REDOX imbalance, oxidative stress and chronic mild inflammatory reaction, etc. Dr is regarded as one of the more serious complications of diabetes. At present, the prevalence of diabetes mellitus (DM) in China continues to increase, while the incidence of DR Continues to rise, and has become the highest blind eye disease in China. The formation process of DR is extremely complex, which is a gradually worsening disease caused by a variety of factors. Although the specific formation principle of DR is not clear at present, relevant studies have pointed out that there is a certain degree of interaction between cytokines and the formation and evolution of DR. In order to deepen the understanding of the influence of cytokines on DR, the correlation between inflammatory index, vascular proliferation-related factors and chemokines and DR will be deeply discussed in this paper, in order to provide a theoretical basis for the study of diabetic retinopathy.

Key words: Cytokines; Diabetes; Retinopathy; Research progress

参考文献 References

[1] 刘雪立.全球糖尿病视网膜病变患病率和2045年负担预测——美国眼科学会报告要点摘编[J].眼科新进展,2024, 44(01):80-81.

[2] 焦晨旭,蔺晓慧.促代谢因子、白介素1β及血管内皮生长因子与糖尿病视网膜病变的相关性研究[J].包头医学院学报,2023,39(12):20-25.

[3] 孙祎遥,赵洋.糖尿病视网膜病变的发病机制及中医治疗进展[J/OL].实用中医内科杂志,1-8[2024-01-11]

[4] 任娅丽.糖尿病视网膜病变患者血清因子水平变化及意义[J].中国卫生工程学,2023,22(05):686-688.

[5] 蒋孟洋,吴泓樾,袁晓辉.糖尿病视网膜病变早期疗法的研究进展[J].糖尿病新世界,2023,26(20):194-198.

[6] 边云,田风胜.贞莲明目胶囊对非增殖期糖尿病视网膜病变白细胞介素-6、白细胞介素-1β、肿瘤坏死因子-α等炎症因子的影响[J].中医临床研究,2023,15(28):37-41.

[7] 张春会,查旭,张远平.糖尿病视网膜病变相关标志物的研究进展[J].眼科新进展,2023,43(09):742-746.

[8] 李丽萍,徐玉霜,汪懿等.增殖性糖尿病性视网膜病变患者玻璃体切割术前应用抗VEGF药物29例疗效观察[J].药品评价,2023,20(08):976-979.

[9] 胡可可,惠延年,杜红俊.抗VEGF时代激光光凝治疗糖尿病视网膜病变的应用进展[J].国际眼科杂志,2023, 23(08): 1285-1289.

[10] 昌路艳,杜瑞琴.全身免疫-炎症指数与糖尿病视网膜病变相关性分析[J].联勤军事医学,2023,37(07):581-584.

[11] 田涛,刘茹,彭婧利等.糖尿病视网膜病变患者血清circFTO和miR-141-3p表达情况及其与病变分期的关系[J]. 国际眼科杂志,2023,23(07):1163-1167.

[12] 解靖,李新章,索南措等.糖尿病视网膜病变患者血清肌肉生长抑制素表达及临床意义[J].中国医药,2023,18(07): 1022-1025.

[13] 高钰寒,董志军.糖尿病视网膜病变炎症相关因子的研究进展[J].承德医学院学报,2023,40(03):241-244.

引用本文

李承泽, 宿星杰, 细胞因子在糖尿病视网膜病变发病中的作用研究进展[J]. 国际临床研究杂志, 2024; 8: (1) : 83-86.